Pitfalls in designing trials of functional dyspepsia: the ascent and demise of itopride.
Veldhuyzen Van Zanten
Sander J O
SJ
Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, Edmonton, Alberta T6G 2X8, Canada. vanzanten@ualberta.ca
D001549:Benzamides / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D004415:Dyspepsia / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D012107:Research Design; D016896:Treatment Outcome
D001549:Benzamides; D001593:Benzyl Compounds; D005765:Gastrointestinal Agents; C102254:itopride